HIV-1 entry inhibitors and virus emergence

被引：0
|
作者：
Richard T. D'Aquila
Michael Hughes
Victoria A. Johnson
机构：
[1] Infectious Disease Division and AIDS Research Center MGH Charlestown,
[2] Harvard School of Public Health Dept. of Biostatistics ,undefined
[3] Div. of Infectious Diseases Depts. of Medicine and Microbiology University of Alabama at Birmingham School of Medicine,undefined
来源：
Nature Medicine | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1091 / 1091
相关论文
共 50 条
  • [41] A new recombinant virus system for the study of HIV-1 entry and inhibition
    Roman, F
    Ammerlaan, W
    Plesseria, JM
    Deroo, S
    Muller, CP
    Arendt, V
    Schneider, F
    Hemmer, R
    Schmit, JC
    JOURNAL OF VIROLOGICAL METHODS, 2006, 131 (01) : 99 - 104
  • [42] Imaging Single Virus Fusion Reveals the HIV-1 Entry Pathway
    Kim, Yuri
    Miyauchi, Kosuke
    Latinovic, Olga
    Melikian, Gregory
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 357A - 357A
  • [43] Resistance to HIV-1 entry inhibitors may occur by multiple molecular mechanisms
    Petropoulos, CJ
    Huang, W
    Toma, J
    Fransen, S
    Bonhoeffer, S
    Whitcomb, JM
    ANTIVIRAL THERAPY, 2004, 9 (04) : U35 - U35
  • [44] Interaction of small molecule inhibitors of HIV-1 entry with CCR5
    Seibert, Christoph
    Ying, Weiwen
    Gavrilov, Svetlana
    Tsamis, Fotini
    Kuhmann, Shawn E.
    Palani, Anandan
    Tagat, Jayaram R.
    Clader, John W.
    McCombie, Stuart W.
    Baroudy, Bahige M.
    Smith, Steven O.
    Dragic, Tatjana
    Moore, John P.
    Sakmar, Thomas P.
    VIROLOGY, 2006, 349 (01) : 41 - 54
  • [45] Rapid microwave-assisted syntheses of derivatives of HIV-1 entry inhibitors
    McFarland, C
    Vicic, DA
    Debnath, AK
    SYNTHESIS-STUTTGART, 2006, 5 (05): : 807 - 812
  • [46] Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitors
    Chen, Weizao
    Dimitrov, Dimiter S.
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (02) : 112 - 117
  • [47] Advances in HIV-1 entry inhibitors: Strategies to interfere with receptor and coreceptor engagement
    Markovic, I
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (09) : 1105 - 1119
  • [48] Antiviral Breadth and Combination Potential of Peptide Triazole HIV-1 Entry Inhibitors
    McFadden, Karyn
    Fletcher, Patricia
    Rossi, Fiorella
    Kantharaju
    Umashankara, Muddagowda
    Pirrone, Vanessa
    Rajagopal, Srivats
    Gopi, Hosahudya
    Krebs, Fred C.
    Martin-Garcia, Julio
    Shattock, Robin J.
    Chaiken, Irwin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (02) : 1073 - 1080
  • [49] Novel endocytosis inhibitors block entry of HIV-1 Tat into neural cells
    Szewczyk-Roszczenko, Olga Klaudia
    Roszczenko, Piotr
    Shmakova, Anna
    Yushyn, Ihor
    Holota, Serhii
    Karpenko, Olexandr
    Czarnomysy, Robert
    Bielawska, Anna
    Vassetzky, Yegor
    Lesyk, Roman
    Bielawski, Krzysztof
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2025, 328 (02): : C404 - C413
  • [50] The Brain Entry of HIV-1 Protease Inhibitors Is Facilitated When Used in Combination
    Marzolini, Catia
    Mueller, Rita
    Li-Blatter, Xiaochun
    Battegay, Manuel
    Seelig, Anna
    MOLECULAR PHARMACEUTICS, 2013, 10 (06) : 2340 - 2349
12345